BehaveNet® Clinical Capsule™:

DSM-IV: Inhalant Intoxication


Dysfunctional changes in physiological functioning, psychological functioning,  mood state, cognitive process, or all of these, as a consequence of consumption of [an inhalant]; usually disruptive, and often stemming from central nervous system impairment.*

Diagnostic criteria for 292.89 Inhalant Intoxication
(cautionary statement)
 

A. Recent intentional use or short-term, high-dose exposure to volatile inhalants (excluding anesthetic gases and short-acting vasodilators). 

B. Clinically significant maladaptive behavioral or psychological changes (e.g., belligerence, assaultiveness, apathy, impaired judgment, impaired social or occupational functioning) that developed during, or shortly after, use of or exposure to volatile inhalants. 

C. Two (or more) of the following signs, developing during, or shortly after, inhalant use or exposure: 

(1) dizziness 
(2) nystagmus 
(3) incoordination 
(4) slurred speech 
(5) unsteady gait 
(6) lethargy 
(7) depressed reflexes 
(8) psychomotor retardation 
(9) tremor 
(10) generalized muscle weakness 
(11) blurred vision or diplopia 
(12) stupor or coma 
(13) euphoria

D. The symptoms are not due to a general medical condition and are not better accounted for by another mental disorder.

Reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorders, fourth Edition. Copyright 1994 American Psychiatric Association

 Netflix, Inc.

Books and Other Media:
Follow the hypertext link to purchase items.

*Excerpt with permission from Graham, Allan W. & Schultz, Terry K. (Editors) Principles of Addiction Medicine, 2nd Edition Hardcover 1998 (American Society of Addiction Medicine)



http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2008 BehaveNet®